Clinical Trial Update: Nilotinib in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating nilotinib in Parkinson's disease has completed and results were posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Nilotinib (nilotinib)

Snippet

Sponsor: Northwestern University | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-07-22